Of particular interest is whether treatment responses to Glucagon-Like Peptide-1 (GLP-1) receptor agonists, especially when combined with diet and exercise, differ depending on the underlying presence of chronic periodontitis. This evidence concerns the gene GLP1R and chronic periodontitis.